NIH-funded research R01 grant

Heart artery disease in people with HIV and latent tuberculosis

Official title: Coronary Atherosclerosis and Immune Activation in HIV and Tuberculosis Infection

Funded at University of Cincinnati · NIH-11170699 · Data updated 2026-11-12

This project looks at whether people living with HIV who also have latent tuberculosis develop more artery plaque and heart disease than those without tuberculosis.

More Tuberculosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Cincinnati
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startAugust 2, 2022
Project endJuly 31, 2027
Funding year2025
Award (this year)$589,109
NIH project number5R01HL156779-04
Project IDNIH-11170699 on NIH RePORTER

Who could benefit from this research

Could help

Adults living with HIV in Lima, Peru, whether they have latent tuberculosis or not, are the intended participants for this project.

Less likely to help

People without HIV, those outside the study region, or those with active tuberculosis (rather than latent infection) are unlikely to be eligible or to receive direct benefit from this project.

What this research studies

You would be asked to join a group of adults living with HIV in Lima, Peru, some who have latent tuberculosis (LTBI) and some who do not. Researchers will use heart artery imaging and blood tests that measure immune activation and inflammation to compare plaque burden and plaque features between the groups. They will also analyze immune cell changes linked to plaque development using blood samples and lab studies informed by earlier mouse experiments. The goal is to link latent TB-related immune changes to artery plaque and risk of obstructive coronary disease in people with HIV.

Why it matters

Potential benefit: If successful, this work could identify latent tuberculosis as a contributor to heart artery disease in people with HIV and point to new ways to reduce that risk.

How similar studies have gone: Previous data linked latent tuberculosis to higher heart attack risk and more obstructive coronary disease in people without HIV and mouse experiments showed more plaque with persistent mycobacterial infection, but this approach has not yet been proven in people living with HIV.

Where this research is happening

  • University of Cincinnati
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Huaman Joo, Moises Arturo — University of Cincinnati
  • Study coordinator: Huaman Joo, Moises Arturo

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.